Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

7,393 total articles

HPE: Riding AI and Networking Demand — Buy the Strength, Not the Dip

HPE: Riding AI and Networking Demand — Buy the Strength, Not the Dip

Hewlett Packard Enterprise is benefitting from accelerating AI inference and networking demand. Q1 beat and an EPS guide of $2.30-$2.50 make today’s $24s an attractive entry for a mid-term swing trade. Valuation (implied forward P/E ~10x) is reasonable vs. cash flow and leverage metrics; the trade is predicated on continued strength in networking a…

Buy the Dip in Goldman Sachs: Near-Term Fog, Secular Upside Intact

Buy the Dip in Goldman Sachs: Near-Term Fog, Secular Upside Intact

Goldman Sachs faces visible headwinds in the near term - slower deal flow, rate-driven trading normalization, and margin pressure - but its franchise, capital position, and pivot to fee-rich businesses justify a longer-term constructive stance. This trade lays out a concrete entry, stop and target with time horizons and catalysts to watch.

Accenture: Valuation Edge and AI Muscle Make it Worth a Re-rating

Accenture: Valuation Edge and AI Muscle Make it Worth a Re-rating

Accenture is a lower-risk way to play enterprise AI adoption and managed services. The stock has been punished despite healthy cash flow, a modest debt load, and ongoing AI investments. At roughly $117.6B market cap and a P/E near 15.5, the risk/reward favors a long position with a clear stop and a target that assumes a modest multiple re-rating al…

Why Novo Nordisk May Face Further Downside as the GLP-1 Fight Intensifies

Why Novo Nordisk May Face Further Downside as the GLP-1 Fight Intensifies

Novo Nordisk sits at the center of an increasingly binary GLP-1 fight. Eli Lilly's recent drug approvals and a stronger clinical edge for some pipeline assets increase the odds of market-share losses; Novo's valuation looks reasonable on paper but may not price in near-term revenue pressure. This trade idea proposes a mid-term short to capture furt…

Volkswagen: Execution Visibility Is Improving — Buy Confirmed

Volkswagen: Execution Visibility Is Improving — Buy Confirmed

Volkswagen ADR (VWAGY) offers an asymmetric setup: a $53.7B market cap, single-digit P/E (7.0), and a 4.3% dividend yield priced into a stock that is bottoming technically. With positive MACD momentum, rising short interest that could fuel squeezes, and tangible progress on partnerships and software monetization, we prefer a tactical long. Entry, s…

Buy Credo (CRDO): Acquisition and Momentum Make the Bear Case Stale

Buy Credo (CRDO): Acquisition and Momentum Make the Bear Case Stale

Credo is executing into the AI connectivity upgrade cycle. The DustPhotonics acquisition, blistering revenue growth and strong margins remove the worst of the bear arguments. This is a tactical-to-position trade: enter on strength or small pullback, protect with a defined stop, and ride a re-rating as optical revenue and AEC momentum compound.

CME Group: Buy the Yield, Hold for Volatility-Driven Upside

CME Group: Buy the Yield, Hold for Volatility-Driven Upside

CME Group (CME) offers a rare combination for income-oriented investors: a high-quality exchange operator with $4.2B in free cash flow last year, a $7.45 per-share distribution that yields about 3.7% at current prices, and a business that benefits when markets get choppy. I like a position-sized, dividend-focused long at current levels with a clear…

CoreWeave: Core Position on the AI Data-Center Buildout

CoreWeave: Core Position on the AI Data-Center Buildout

CoreWeave sits at the nexus of GPU-driven AI demand and hyperscaler data-center spending. Recent multi-year deals with Meta and Anthropic, an enlarged $21B Meta expansion, and price increases give the company a clear runway for revenue and margin improvement. Valuation is rich for a loss-making operator, but for patient, risk-tolerant investors thi…

Snowflake: Sentiment Snapped — Sell Puts, Not Stocks

Snowflake: Sentiment Snapped — Sell Puts, Not Stocks

Snowflake (SNOW) is trading well below its 52-week highs after a sectorwide software selloff and fresh legal headlines. Fundamentals still support long-term demand for a modern data cloud, but valuation and momentum favor option sellers today. My trade: sell cash-secured puts in the mid-term (45 trading days) to collect premium and be paid to own t…